COVID-19 and Diabetes; Post-COVID Diabetes

Patients with diabetes mellitus have a higher risk of developing coronavirus disease 2019 (COVID-19), which is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 may potentially increase the risk of hyperglycemia in infected people. Hyperglycemia, in combination with other risk factors, may modulate immunological and inflammatory responses, predisposing individuals to severe COVID-19 and potentially fatal results. Patients with diabetes mellitus should be aware that COVID-19 can raise blood glucose levels, thus they should adhere to clinical guidelines for diabetes mellitus management more closely during the COVID-19 pandemic.

Even as the world recovers from the second pandemic wave, post-Covid symptoms in recovered patients are causing concern. Diabetes has arisen as a major health risk among the Covid-recovered patients. In a worrisome development, almost one crore persons who survived the infection around the world have now developed diabetes, despite the fact that their blood sugar levels were previously normal.

• Controlling glucose levels in pandemic
• Inflammation and diabetes
• Immunology and diabetes
• Diabetes after COVID-19 positive